Chemokines and Cytokines Profiles in Patients with Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis: A Preliminary Study. [PDF]
Daca A +5 more
europepmc +1 more source
Gingivitis y Anticuerpos Anticitoplasmáticos de Neutrófilos en niños y adolescentes con leucemia [PDF]
Introducción: Las enfermedades sistémicas pueden originar y exacerbar alteraciones en el periodonto. Se ha demostrado la presencia de Anticuerpos Anticitoplasmáticos de neutrófi los (ANCA) en pacientes con enfermedad periodontal destructiva y con ...
Navas, Rita +4 more
core +1 more source
Limited Antineutrophil Cytoplasmic Antibodies (ANCA)-Negative Granulomatosis With Polyangiitis: Successful Response to Rituximab. [PDF]
Andrade MM +3 more
europepmc +1 more source
Improvement of indirect immunofluorescence technique to detect antineutrophil cytoplasmic antibodies and its impact on test positivity rate. [PDF]
Zarur EB +6 more
europepmc +1 more source
Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial [PDF]
Peter A. Merkel +4 more
openalex +1 more source
Antieosinophil Antibodies Alone or in Combination with Antineutrophil Cytoplasmic Antibodies (ANCA) Detected in Different Autoimmune Conditions. [PDF]
Dieckmann R +6 more
europepmc +1 more source
Background Tularemia is a zoonotic disease that is rarely diagnosed in Europe. Its clinical presentation is highly variable, requiring consideration of a broad differential diagnosis.
Matthias Feyrer +4 more
doaj +1 more source
Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature. [PDF]
Van Gool IC +5 more
europepmc +1 more source
Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody: Technical Note [PDF]
Kerstin Westman +6 more
openalex +1 more source

